The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Soluble Interleukin-15 Receptor α (IL-15Rα)-sushi as a Selective and Potent Agonist of IL-15 Action through IL-15Rβ/γ
Open accessAbstract
Interleukin-15 (IL-15) is crucial for the generation of multiple lymphocyte subsets (natural killer (NK), NK-T cells, and memory CD8 T cells), and transpresentation of IL-15 by monocytes and dendritic cells has been suggested to be the dominant activating process of these lymphocytes. We have previously shown that a natural soluble form of IL-15R alpha chain corresponding to the entire extracellular domain of IL-15R alpha behaves as a high affinity IL-15 antagonist. In sharp contrast with this finding, we demonstrate in this report that a recombinant, soluble sushi domain of IL-15R alpha, which bears most of the binding affinity for IL-15, behaves as a potent IL-15 agonist by enhancing its binding and biological effects (proliferation and protection from apoptosis) through the IL-15R beta/gamma heterodimer, whereas it does not affect IL-15 binding and function of the tripartite IL-15R alpha/beta/gamma membrane receptor. Our results suggest that, if naturally produced, such soluble sushi domains might be involved in the IL-15 transpresentation mechanism. Fusion proteins (RLI and ILR), in which IL-15 and IL-15R alpha-sushi are attached by a flexible linker, are even more potent than the combination of IL-15 plus sIL-15R alpha-sushi. After binding to IL-15R beta/gamma, RLI is internalized and induces a biological response very similar to the IL-15 high affinity response. Such hyper-IL-15 fusion proteins appear to constitute potent adjuvants for the expansion of lymphocyte subsets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Mast Cells Express Novel Functional IL-15 Receptor α Isoforms
Bulanova, E., Budagian, V., Orinska, Z., Krause, H., Paus, R., & Bulfone‐Paus, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.10.5045 · Cited by 45
RetractedReversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice
Kennedy, M. K., Glaccum, M., Brown, S. N., Butz, E. A., Viney, J. L., Embers, M., Matsuki, N., Charrier, K., Sedger, L., Willis, C. R., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.5.771 · Cited by 1,634
Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
Grabstein, K. H., Eisenman, J., Shanebeck, K., Rauch, C., Srinivasan, S., Fung, V., Beers, C., Richardson, J., Schoenborn, M. A., Ahdieh, M., et al. (1994) · Science · doi:10.1126/science.8178155 · Cited by 1,422
Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., & Caligiuri, M. A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1395 · Cited by 1,092
Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15.
Giri, J. G., Ahdieh, M., Eisenman, J., Shanebeck, K., Grabstein, K., Kumaki, S., Namen, A., Park, L. S., Cosman, D., & Anderson, D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06576.x · Cited by 981
IL-15Rα Recycles and Presents IL-15 In trans to Neighboring Cells
Dubois, S., Mariner, J., Waldmann, T. A., & Tagaya, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00429-6 · Cited by 913
Control of Homeostasis of CD8 + Memory T Cells by Opposing Cytokines
Ku, C. C., Murakami, M., Sakamoto, A., Kappler, J., & Marrack, P. (2000) · Science · doi:10.1126/science.288.5466.675 · Cited by 816
Soluble receptors for cytokines and growth factors: generation and biological function
Rose-John, S., & Heinrich, P. C. (1994) · Biochemical Journal · doi:10.1042/bj3000281 · Cited by 775
A bioactive designer cytokine for human hematopoietic progenitor cell expansion
Fischer, M., Goldschmitt, J., Peschel, C., Brakenhoff, J. P. G., Kallen, K.-J., Wollmer, A., Grötzinger, J., & Rose-John, S. (1997) · Nature Biotechnology · doi:10.1038/nbt0297-142 · Cited by 530
Self-citationIL-2-induced activation-induced cell death is inhibited in IL-15 transgenic mice
Marks-Konczalik, J., Dubois, S., Losi, J. M., Sabzevari, H., Yamada, N., Feigenbaum, L., Waldmann, T. A., & Tagaya, Y. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.200363097 · Cited by 433
Burton, J. D., Bamford, R. N., Peters, C., Grant, A. J., Kurys, G., Goldman, C. K., Brennan, J., Roessler, E., & Waldmann, T. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4935 · Cited by 397
Anderson, D. M., Kumaki, S., Ahdieh, M., Bertles, J., Tometsko, M., Loomis, A., Giri, J., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.50.29862 · Cited by 372
Released Form of CNTF Receptor α Component as a Soluble Mediator of CNTF Responses
Davis, S., Aldrich, T. H., Ip, N. Y., Stahl, N., Scherer, S., Farruggella, T., DiStefano, P. S., Curtis, R., Panayotatos, N., Gascan, H., et al. (1993) · Science · doi:10.1126/science.7681218 · Cited by 350
Nakamura, Y., Russell, S. M., Mess, S. A., Friedmann, M., Erdos, M., Francois, C., Jacques, Y., Adelstein, S., & Leonard, W. J. (1994) · Nature · doi:10.1038/369330a0 · Cited by 337
Self-citationIL-15 and IL-2: a matter of life and death for T cells in vivo
Li, X. C., Demirci, G., Ferrari-Lacraz, S., Groves, C., Coyle, A., Malek, T. R., & Strom, T. B. (2001) · Nature Medicine · doi:10.1038/83253 · Cited by 312
Ruchatz, H., Leung, B. P. L., Wei, X., McInnes, I. B., & Liew, F. Y. (1998) · PubMed · Cited by 290
Chemoattraction of human blood T lymphocytes by interleukin-15.
Wilkinson, P. C., & Liew, F. Y. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.3.1255 · Cited by 290
Kobayashi, H., Dubois, S., Sato, N., Sabzevari, H., Sakai, Y., Waldmann, T. A., & Tagaya, Y. (2005) · Blood · doi:10.1182/blood-2003-12-4187 · Cited by 275
A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu, B., Hsu, S.-M., Ho, H., Lien, H., Huang, S., & Lin, R. H. (2001) · PubMed · Cited by 268
Jones, S. A., & Rose-John, S. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00319-1 · Cited by 255
CLF associates with CLC to form a functional heteromeric ligand for the CNTF receptor complex
Elson, G. C. A., Lelièvre, E., Guillet, C., Chevalier, S., Plun-Favreau, H., Froger, J., Suard, I., de Coignac, A. B., Delneste, Y., Bonnefoy, J.-Y., et al. (2000) · Nature Neuroscience · doi:10.1038/78765 · Cited by 252
Koka, R., Burkett, P. R., Chien, M., Chai, S., Chan, F., Lodolce, J. P., Boone, D. L., & Ma, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021836 · Cited by 252
Schulz, O., Sewell, H. F., & Shakib, F. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.2.271 · Cited by 251
Three-dimensional structure of a complement control protein module in solution
Norman, D. G., Barlow, P. N., Baron, M., Day, A. J., Sim, R. B., & Campbell, I. D. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90666-t · Cited by 241
Ruchatz, H., Leung, B. P., Wei, X.-Q., McInnes, I. B., & Liew, F. Y. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5654 · Cited by 219
T Cell–Independent Interleukin 15rα Signals Are Required for Bystander Proliferation
Lodolce, J. P., Burkett, P. R., Boone, D. L., Chien, M., & Ma, A. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1187 · Cited by 176
Sandau, M. M., Schluns, K. S., Lefrancois, L., & Jameson, S. C. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6537 · Cited by 175
Soluble receptors in human disease
Heaney, M. L., & Golde, D. W. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.64.2.135 · Cited by 173
Hori, T., Uchiyama, T., Tsudo, M., Umadome, H., Ohno, H., Fukuhara, S., Kita, K., & Uchino, H. (1987) · Blood · doi:10.1182/blood.v70.4.1069.1069 · Cited by 170
Schluns, K. S., Nowak, E. C., Cabrera-Hernandez, A., Puddington, L., Lefrançois, L., & Aguila, H. L. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307442101 · Cited by 162
IL-15Rα expression on CD8 + T cells is dispensable for T cell memory
Burkett, P. R., Koka, R. M., Chien, M., Chai, S., Chan, F., Ma, A. I., & Boone, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0737048100 · Cited by 154
Mortier, E., Bernard, J., Plet, A., & Jacques, Y. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1681 · Cited by 143
Self-citationGiron‐Michel, J., Giuliani, M., Fogli, M., Brouty‐Boyé, D., Ferrini, S., Baychelier, F., Eid, P., Bousse‐Kerdilès, M. L., Duralı, D., Biassoni, R., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0064 · Cited by 96
Dubois, S. P., Magrangeas, F., Lehours, P., Raher, S., Bernard, J., Boisteau, O., Leroy, S., Minvielle, S., Godard, A., & Jacques, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.26978 · Cited by 94
Self-citationPflanz, S., Tacken, I., Grötzinger, J., Jacques, Y., Dahmen, H., Heinrich, P. C., & Müller‐Newen, G. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00477-9 · Cited by 55
Self-citationKarow, J., Hudson, K., HALL, M. A., Vernallis, A. B., TAYLOR, J. A., Gossler, A., & Heath, J. K. (1996) · Biochemical Journal · doi:10.1042/bj3180489 · Cited by 52
Meazza, R., Basso, S., Gaggero, A., de Totero, D., Trentin, L., Pereno, R., Azzarone, B. G., & Ferrini, S. (1998) · International Journal of Cancer · Cited by 38
Cited by
Cytokines in clinical cancer immunotherapy
Berraondo, P., Sanmamed, M. F., Ochoa, M. C., Etxeberria, I., Aznar, M. A., Pérez-Gracia, J. L., Rodríguez-Ruiz, M. E., Ponz-Sarvise, M., Castañón, E., & Melero, I. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0328-y · Cited by 1,205
Effector and Memory CTL Differentiation
Williams, M. A., & Bevan, M. J. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141548 · Cited by 949
IL-15 trans-presentation promotes human NK cell development and differentiation in vivo
Huntington, N. D., Legrand, N., Alves, N. L., Jaron, B., Weijer, K., Plet, A., Corcuff, E., Mortier, E., Jacques, Y., Spits, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082013 · Cited by 577
Self-citationNK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy
Wang, W. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00368 · Cited by 567
Cytokines in the Treatment of Cancer
Conlon, K. C., Miljkovic, M. D., & Waldmann, T. A. (2019) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2018.0019 · Cited by 518
Metadata
- Authors
- Mortier, E., Quéméner, A., Vusio, P., Lorenzen, I., Boublik, Y., Grötzinger, J., Plet, A., & Jacques, Y.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-01
- Volume
- 281
- Issue
- 3
- Pages
- 1612-1619
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1570245632
- Cited by
- 308
- References
- 37
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.